Cadegiani, 778 patient proxalutamide late treatment RCT: 78% lower mortality [p<0.0001], 45% improved recovery [p<0.0001], and 33% lower hospitalization [p=0.0001] https://c19p.org/cadegiani10
copied to clipboard
Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
et al., Cureus, doi:10.7759/cureus.20691
RCT 778 hospitalized patients in Brazil, 423 treated with proxalutamide, showing significantly lower mortality and improved recovery with treatment. NCT04728802 and NCT05126628. Authors note that cases in this trial were predominantly the P.1 Gamma variant, for which proxalutamide may be more effective compared to other variants.
|
risk of death, 78.0% lower, RR 0.22, p < 0.001, treatment 45 of 423 (10.6%), control 171 of 355 (48.2%), NNT 2.7, adjusted per study, 28 days, Cox proportional hazards.
|
|
risk of death, 79.0% lower, RR 0.21, p < 0.001, treatment 34 of 423 (8.0%), control 138 of 355 (38.9%), NNT 3.2, adjusted per study, 14 days, Cox proportional hazards.
|
|
recovery rate, RR 0.55, p < 0.001, treatment 423, control 355, adjusted per study, 28 days, Cox proportional hazards.
|
|
recovery rate, RR 0.45, p < 0.001, treatment 423, control 355, adjusted per study, 14 days, Cox proportional hazards, primary outcome.
|
|
hospitalization time, 33.3% lower, relative time 0.67, p < 0.001, treatment 423, control 355.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Cadegiani et al., 12/25/2021, Double Blind Randomized Controlled Trial, Brazil, South America, peer-reviewed, 15 authors, trial NCT04728802.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.